Tumor biomarker testing in non-small-cell lung cancer: a decade of change

INTRODUCTION: Although a growing list of essential genomic/immune-based biomarkers are linked to approved non-small-cell lung cancer (NSCLC) therapies worldwide, few reports have detailed the evolution of NSCLC predictive biomarker assessment in routine clinical practice. METHODS: We retrospectively...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lung Cancer
Main Authors: VanderLaan, Paul A., Rangachari, Deepa, Majid, Adnan, Parikh, Mihir S., Gangadharan, Sidharta P., Kent, Michael S., McDonald, Danielle C., Huberman, Mark S., Kobayashi, Susumu S., Costa, Daniel B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5806129/
https://ncbi.nlm.nih.gov/pubmed/29413057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2018.01.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados